Hennessy Advisors Inc Gilead Sciences, Inc. Transaction History

Hennessy Advisors Inc

$2.35 Billion
Q1 2024

A detailed history of Hennessy Advisors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hennessy Advisors Inc holds 61,100 shares of GILD stock, worth $4.18 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

61,100

Holding current value

$4.18 Million

% of portfolio

0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$71.58 - $87.29 $4.37 Million - $5.33 Million	61,100 New	61,100 $4.48 Million
Q4 2023 Jan 18, 2024	SELL	$73.27 - $83.09 $256,445 - $290,815	-3,500 Reduced 5.45%	60,700 $4.92 Million
Q3 2023 Oct 18, 2023	SELL	$73.94 - $80.67 $96,122 - $104,871	-1,300 Reduced 1.98%	64,200 $4.81 Million
Q2 2023 Jul 17, 2023	SELL	$76.01 - $86.7 $288,838 - $329,460	-3,800 Reduced 5.48%	65,500 $5.05 Million
Q1 2023 Apr 14, 2023	SELL	$77.31 - $88.08 $5.95 Million - $6.77 Million	-76,900 Reduced 52.6%	69,300 $5.75 Million

Q4 2022 Jan 20, 2023	SELL	$62.32 - $89.47 $299,136 - $429,456	-4,800 Reduced 3.18%	146,200 $12.6 Million
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $5,954 - $6,801	-100 Reduced 0.07%	151,000 $9.32 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $63,492 - $71,511	-1,100 Reduced 0.72%	151,100 $9.34 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $4.66 Million - $5.84 Million	80,500 Added 112.27%	152,200 $9.05 Million
Q4 2021 Jan 25, 2022	SELL	$64.88 - $73.64 $110,295 - $125,188	-1,700 Reduced 2.32%	71,700 $5.21 Million
Q3 2021 Oct 12, 2021	SELL	$67.69 - $73.03 $74,459 - $80,333	-1,100 Reduced 1.48%	73,400 $5.13 Million
Q1 2021 Apr 19, 2021	BUY	$60.0 - $68.46 $516,000 - $588,756	8,600 Added 13.05%	74,500 $4.82 Million
Q4 2020 Jan 25, 2021	SELL	$56.65 - $64.55 $220,935 - $251,745	-3,900 Reduced 5.59%	65,900 $3.84 Million
Q3 2020 Oct 16, 2020	SELL	$62.1 - $78.08 $99,360 - $124,928	-1,600 Reduced 2.24%	69,800 $4.41 Million
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $94,042 - $109,200	-1,300 Reduced 1.79%	71,400 $5.49 Million
Q1 2020 Apr 14, 2020	BUY	$62.63 - $80.22 $37,578 - $48,132	600 Added 0.83%	72,700 $5.44 Million
Q4 2019 Jan 14, 2020	SELL	$61.62 - $67.78 $209,508 - $230,452	-3,400 Reduced 4.5%	72,100 $4.69 Million
Q3 2019 Oct 07, 2019	SELL	$62.51 - $69.0 $131,271 - $144,900	-2,100 Reduced 2.71%	75,500 $4.79 Million
Q1 2019 Apr 08, 2019	BUY	$62.53 - $70.05 $656,565 - $735,525	10,500 Added 15.65%	77,600 $5.05 Million
Q4 2018 Jan 14, 2019	SELL	$60.54 - $79.0 $145,296 - $189,600	-2,400 Reduced 3.45%	67,100 $4.2 Million
Q1 2018 May 02, 2018	BUY	$72.84 - $88.8 $2.86 Million - $3.48 Million	39,200 Added 129.37%	69,500 $5.24 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $2.18 Million - $2.59 Million	30,300	30,300 $2.46 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $85.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hennessy Advisors Inc with notifications on news.

Account

Hennessy Advisors Inc Gilead Sciences, Inc. Transaction History